Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
$7.20
-3.0%
$4.51
$2.84
$11.50
$392.69M2.364.82 million shs5.79 million shs
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
C$5.72
-1.7%
C$5.49
C$4.35
C$5.95
C$578.69M0.4973,669 shs21,992 shs
HEXO Corp. stock logo
HEXO
HEXO
$0.71
+2.5%
$0.87
$0.66
$3.84
$31.24M1.35880,508 shs305,500 shs
Leaf Group Ltd. stock logo
LEAF
Leaf Group
$8.49
$8.47
$2.48
$9.50
$305.91M2.13959,348 shsN/A
Organigram Holdings Inc. stock logo
OGI
Organigram
$1.93
-1.0%
$2.09
$0.97
$2.91
$199.18M1.091.36 million shs775,826 shs
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
-2.96%+24.35%+73.91%+77.78%+27.66%
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
-1.72%-2.39%+8.95%+3.81%+19.42%
HEXO Corp. stock logo
HEXO
HEXO
0.00%0.00%0.00%0.00%-37.72%
Leaf Group Ltd. stock logo
LEAF
Leaf Group
0.00%0.00%0.00%0.00%0.00%
Organigram Holdings Inc. stock logo
OGI
Organigram
-1.03%+5.46%-23.41%+19.14%-5.15%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
0.2234 of 5 stars
0.02.00.00.03.00.80.6
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
0.6872 of 5 stars
2.50.00.00.00.03.30.6
HEXO Corp. stock logo
HEXO
HEXO
N/AN/AN/AN/AN/AN/AN/AN/A
Leaf Group Ltd. stock logo
LEAF
Leaf Group
N/AN/AN/AN/AN/AN/AN/AN/A
Organigram Holdings Inc. stock logo
OGI
Organigram
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
3.00
BuyN/AN/A
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
3.00
BuyC$6.5815.09% Upside
HEXO Corp. stock logo
HEXO
HEXO
N/AN/AN/AN/A
Leaf Group Ltd. stock logo
LEAF
Leaf Group
N/AN/AN/AN/A
Organigram Holdings Inc. stock logo
OGI
Organigram
3.00
BuyN/AN/A

Current Analyst Ratings

Latest ACB, LEAF, OGI, HEXO, and GUD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/15/2024
Organigram Holdings Inc. stock logo
OGI
Organigram
Alliance Global Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy
3/22/2024
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperformC$6.50 ➝ C$7.00
3/6/2024
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperformC$7.00 ➝ C$7.50
2/28/2024
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetOutperformC$7.00
2/9/2024
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy
(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
$174.88M2.25N/AN/AN/A
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
C$328.20M1.76C$1.49 per share3.85C$7.38 per share0.78
HEXO Corp. stock logo
HEXO
HEXO
$146.20M0.21N/AN/A$2.44 per share0.29
Leaf Group Ltd. stock logo
LEAF
Leaf Group
$212.06M1.44$0.02 per share400.34$2.19 per share3.88
Organigram Holdings Inc. stock logo
OGI
Organigram
$120.01M1.66N/AN/A$2.48 per share0.78

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
-$799.22M-$2.90N/AN/AN/A-48.82%-23.27%-15.75%6/12/2024 (Estimated)
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
-C$16.84M-C$0.16N/AN/A-5.13%-2.14%0.40%5/9/2024 (Estimated)
HEXO Corp. stock logo
HEXO
HEXO
-$845.90M-$5.21N/AN/AN/A-235.33%-74.04%-32.51%N/A
Leaf Group Ltd. stock logo
LEAF
Leaf Group
-$8.86MN/AN/AN/A-1.94%-7.40%-3.79%N/A
Organigram Holdings Inc. stock logo
OGI
Organigram
-$184.34M-$0.80N/AN/AN/A-173.48%-30.94%-27.70%4/30/2024 (Estimated)

Latest ACB, LEAF, OGI, HEXO, and GUD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/21/2024Q4 2023
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
C$0.02-C$0.03-C$0.05C$0.17C$78.37 millionC$74.20 million
2/13/2024Q1 2024
Organigram Holdings Inc. stock logo
OGI
Organigram
-$0.10-$0.14-$0.04-$0.14$28.61 million$26.78 million
2/8/2024Q3 2024
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
-$0.10-$0.20-$0.10N/A$45.94 million$53.34 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
N/AN/AN/AN/AN/A
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
N/AN/AN/AN/AN/A
HEXO Corp. stock logo
HEXO
HEXO
N/AN/AN/AN/AN/A
Leaf Group Ltd. stock logo
LEAF
Leaf Group
N/AN/AN/AN/AN/A
Organigram Holdings Inc. stock logo
OGI
Organigram
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
0.14
3.79
2.45
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
9.25
3.20
1.79
HEXO Corp. stock logo
HEXO
HEXO
0.01
0.41
0.24
Leaf Group Ltd. stock logo
LEAF
Leaf Group
0.01
1.65
1.65
Organigram Holdings Inc. stock logo
OGI
Organigram
N/A
4.28
2.11

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
47.63%
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
13.67%
HEXO Corp. stock logo
HEXO
HEXO
7.78%
Leaf Group Ltd. stock logo
LEAF
Leaf Group
70.80%
Organigram Holdings Inc. stock logo
OGI
Organigram
34.63%

Insider Ownership

CompanyInsider Ownership
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
0.01%
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
46.45%
HEXO Corp. stock logo
HEXO
HEXO
4.69%
Leaf Group Ltd. stock logo
LEAF
Leaf Group
11.40%
Organigram Holdings Inc. stock logo
OGI
Organigram
0.09%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
1,13054.54 million54.53 millionOptionable
Knight Therapeutics Inc. stock logo
GUD
Knight Therapeutics
725101.17 millionN/ANot Optionable
HEXO Corp. stock logo
HEXO
HEXO
1,27744.00 million41.93 millionOptionable
Leaf Group Ltd. stock logo
LEAF
Leaf Group
36036.03 millionN/AOptionable
Organigram Holdings Inc. stock logo
OGI
Organigram
984103.20 million103.11 millionOptionable

ACB, LEAF, OGI, HEXO, and GUD Headlines

SourceHeadline
Organigram (NASDAQ:OGI) Upgraded by Alliance Global Partners to "Buy"Organigram (NASDAQ:OGI) Upgraded by Alliance Global Partners to "Buy"
americanbankingnews.com - April 16 at 4:50 AM
Organigram (NASDAQ:OGI) Lifted to Buy at Alliance Global PartnersOrganigram (NASDAQ:OGI) Lifted to Buy at Alliance Global Partners
marketbeat.com - April 15 at 9:11 AM
Analysts Are Bullish on These Healthcare Stocks: Tonix Pharma (TNXP), OrganiGram Holdings (OGI)Analysts Are Bullish on These Healthcare Stocks: Tonix Pharma (TNXP), OrganiGram Holdings (OGI)
markets.businessinsider.com - April 11 at 1:36 PM
Organigram Recognized for Executive Gender Diversity by the Globe & Mails Women Lead Here Report for the Fourth Consecutive YearOrganigram Recognized for Executive Gender Diversity by the Globe & Mail's Women Lead Here Report for the Fourth Consecutive Year
stockhouse.com - April 10 at 5:10 PM
Q2 2024 EPS Estimates for Organigram Holdings Inc. Increased by Atb Cap Markets (NASDAQ:OGI)Q2 2024 EPS Estimates for Organigram Holdings Inc. Increased by Atb Cap Markets (NASDAQ:OGI)
marketbeat.com - April 5 at 8:21 AM
Organigram’s Popular SHRED Brand Surpasses $200 Million in Yearly Retail SalesOrganigram’s Popular SHRED Brand Surpasses $200 Million in Yearly Retail Sales
finance.yahoo.com - April 3 at 8:37 AM
Organigrams Popular SHRED Brand Surpasses $200 Million in Yearly Retail SalesOrganigram's Popular SHRED Brand Surpasses $200 Million in Yearly Retail Sales
businesswire.com - April 3 at 8:06 AM
Organigram Successfully Closes Previously Announced Underwritten Public OfferingOrganigram Successfully Closes Previously Announced Underwritten Public Offering
businesswire.com - April 2 at 8:51 AM
Organigram (NASDAQ:OGI) Stock Price Down 6.3%Organigram (NASDAQ:OGI) Stock Price Down 6.3%
marketbeat.com - March 30 at 12:43 AM
Why OrganiGram (OGI) Might Surprise This Earnings SeasonWhy OrganiGram (OGI) Might Surprise This Earnings Season
zacks.com - March 28 at 9:56 AM
Why OrganiGram (OGI) Stock Is DivingWhy OrganiGram (OGI) Stock Is Diving
msn.com - March 27 at 3:18 PM
Organigram Sells Units to Raise C$25 MIllionOrganigram Sells Units to Raise C$25 MIllion
newcannabisventures.com - March 27 at 10:18 AM
Organigram Announces Pricing of Overnight Marketed Public OfferingOrganigram Announces Pricing of Overnight Marketed Public Offering
businesswire.com - March 27 at 8:56 AM
Organigram Announces Launch of Overnight Marketed Public OfferingOrganigram Announces Launch of Overnight Marketed Public Offering
businesswire.com - March 26 at 7:06 PM
Organigram Invests in U.S. Based Open Book Extracts Representing Inaugural Jupiter InvestmentOrganigram Invests in U.S. Based Open Book Extracts Representing Inaugural Jupiter Investment
businesswire.com - March 26 at 1:36 PM
OGI Sep 2024 6.000 callOGI Sep 2024 6.000 call
finance.yahoo.com - March 26 at 12:10 AM
OGI Jun 2024 4.000 putOGI Jun 2024 4.000 put
finance.yahoo.com - March 26 at 12:10 AM
Organigram ‘assessing options’ after unfavorable ruling on cannabis ediblesOrganigram ‘assessing options’ after unfavorable ruling on cannabis edibles
mjbizdaily.com - March 26 at 12:10 AM
The Marijuana Stocks Could See A Rise This WeekThe Marijuana Stocks Could See A Rise This Week
marijuanastocks.com - March 24 at 9:40 AM
Organigram Receives Health Canadas Final Redetermination on JoltsOrganigram Receives Health Canada's Final Redetermination on Jolts
businesswire.com - March 22 at 7:00 PM
Finding the Next Big Winners: 3 Stocks You Can Snag for Under $5Finding the Next Big Winners: 3 Stocks You Can Snag for Under $5
investorplace.com - March 21 at 4:05 PM
OGI Apr 2024 2.000 putOGI Apr 2024 2.000 put
finance.yahoo.com - March 17 at 12:08 AM
Top Marijuana Stocks For Trading Today 2024Top Marijuana Stocks For Trading Today 2024
marijuanastocks.com - March 6 at 9:06 AM
2 Top Marijuana Penny Stocks with High Momentum Before March 20242 Top Marijuana Penny Stocks with High Momentum Before March 2024
marijuanastocks.com - March 2 at 11:00 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Aurora Cannabis logo

Aurora Cannabis

NASDAQ:ACB
Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, the Caribbean, South America, and Israel; supply of propagated vegetables and ornamental plants in North America; and distribution and sale of hemp-derived cannabidiol (CBD) products. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried flowers, vapes, dried milled strains, strain-specific extracts, strain specific cannabis oils, and concentrates. Further, it offers recreational cannabis products, such as flowers, vapes, ingestibles, concentrates, extracts, and CBD products; and patient counseling and outreach services. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.
Knight Therapeutics logo

Knight Therapeutics

TSE:GUD
Knight Therapeutics Inc. develops, manufactures, acquires, in-licenses, out-licenses, markets, and distributes pharmaceutical and consumer health products, and medical devices worldwide. It offers Tafasitamab for relapsed or refractory diffuse large B-cell lymphoma; Pemigatinib for metastatic cholangiocarcinoma; Akynzeo for prevention of chemotherapy-induced acute and delayed nausea and vomiting; Aloxi for prevention of acute nausea and vomiting associated with emetogenic cancer chemotherapy; Fostamatinib for chronic immune thrombocytopenia; Nerlynx for extended adjuvant breast cancer and metastatic breast cancer; Trelstar for advanced prostate cancer; Vidaza for myelodysplastic syndrome; Abraxane for metastatic pancreatic cancer; Halaven for metastatic breast cancer and soft tissue sarcoma; and Lenvima for advanced renal cell cancer and for differentiated thyroid cancer and unresectable hepatocellular carcinoma. The company provides Ladecvina for multiple myeloma and myelodysplastic syndrome, mantle cell lymphoma, and follicular lymphoma; Zyvalix for metastatic prostate cancer; Karfib for relapsed or refractory multiple myeloma; Leprid for advanced prostate cancer; Rembre for chronic myeloid leukemia; Palbocil for breast cancer; Ambisome and Cresemba for fungal infection; Impavido for leishmaniasis; Dolufevir for HIV infection; Exelon for dementia; and Ibsrela for irritable bowel syndrome with constipation. In addition, it offers Salofalk for ulcerative colitis; Ursofalk for biliary cirrhosis; Imvexxy for moderate to severe dyspareunia; Bijuva for vasomotor symptoms; Fibridoner for idiopathic pulmonary fibrosis; Toliscrin DPI for pseudomonas aeruginosa lung infection; Toliscrin 1-2 for severe acute or resistant chronic infections; and Tobradosa Haler for chronic lung infections. Further, it finances other life science companies; and invests in life sciences venture capital funds. The company was incorporated in 2013 and is headquartered in Montreal, Canada.
HEXO logo

HEXO

NYSE:HEXO
HEXO Corp., together with its subsidiaries, produces, markets, and sells cannabis in Canada. The company offers its adult-use and medical products under the HEXO brand name. It also provides cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brands; and cannabis products under UP Cannabis, Original Stash, and Up brand names. It has a strategic alliance with Tilray Brands, Inc. The company was formerly known as The Hydropothecary Corporation and changed its name to HEXO Corp. in August 2018. HEXO Corp. was founded in 2013 and is headquartered in Gatineau, Canada. As of June 22, 2023, HEXO Corp. operates as a subsidiary of Tilray Brands, Inc.
Leaf Group logo

Leaf Group

NYSE:LEAF
Leaf Group Ltd., together with its subsidiaries, operates as a diversified consumer internet company worldwide. It operates in two segments, Marketplaces and Media. The Marketplaces segment offers Society6.com, which provides artists with an online commerce platform to feature and sell their original art and designs on consumer products in the wall art, home décor, and tech and apparel accessories categories. It also provides SaatchiArt.com and its related art fair event brand, which is an online art gallery where a global community of artists exhibit and sell their original artwork directly to consumers. The Media segment offers Well+Good, a health and wellness media brand that offers journalistic approach to content; and Livestrong.com, a destination and action-oriented community, as well as mobile applications, such as MyPlate that monitor users' health, fitness, and life achievements. This segment also provides Hunker, a home design media site for enabling first-time homeowners enhance their homes with practical solutions, home tours, and design advice for people; and Only In Your State, a US-focused local attractions and review site, which highlights small businesses, hidden gems, and natural wonders for the audience. In addition, this segment offers content creation, traffic source, mobile application, and monetization services; and develops partner sites. It sells its products through wholesale channels to trade and hospitality clients, as well as through retail distribution partners. The company was formerly known as Demand Media, Inc. and changed its name to Leaf Group Ltd. in November 2016. Leaf Group Ltd. was incorporated in 2006 and is headquartered in Santa Monica, California.
Organigram logo

Organigram

NASDAQ:OGI
Organigram Holdings Inc., through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Edison JOLTS, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative-based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as consumer channels. The company was incorporated in 2010 and is headquartered in Toronto, Canada.